Prot# 20101217: A Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy and Safety of Denosumab Compared With Risedronate in Glucocorticoid-treated Individuals

Project: Research project

Project Details

StatusFinished
Effective start/end date5/17/125/17/18

Funding

  • Amgen, Inc. (20101217)